Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development

Chia Hung Yen, Chih Chung Lai, Chen Chung Liao, Sheng Fan Wang, Yi Jen Liao, Chien Yi Tung, Jung Hsien Hung, Shiu Feng Huang, Yi Ming Arthur Chen

Research output: Contribution to journalArticle

Abstract

Sarcomatoid hepatocellular carcinoma (SHC) is a rare type of HCC with significantly poorer survival than ordinary HCC. Little is known about the mechanism associated with SHC and its biomarkers and therapy. Here, we established a mouse liver cancer cell line and designated as Ymac-1. A sarcomatous appearance was observed in the allograft tumor arose from Ymac-1. Liver-secreted plasma proteins were found in Ymac-1 cultured supernatant by proteomics analysis. The positive staining of CK7, CK8, Vimentin and the suppressed expression of AFP indicated that Ymac-1 is a SHC cell line. Compared to its original tumor, an elevated level of EMT markers, N-cadherin and Vimentin, was found in Ymac-1. Ymac-1 displayed a higher migration rate and side population percentage than a mouse ordinary HCC cell line-Hepa1-6. Microarray analysis was performed to identify potential biomarkers/therapeutic targets for SHC. G6pd, a vital enzyme in pentose phosphate pathway, is highly expressed in Ymac-1. Depletion of G6pd in Ymac-1 reduced CD133 expression and sphere formation. Positive correlations between G6PD and CD133 were observed in human specimen. Higher expression of both G6PD and CD133 in tumor were associated with poor survival. In summary Ymac-1 can be a useful SHC cell model for novel biomarker and therapy development.

Original languageEnglish
Article number3052
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Hepatocellular Carcinoma
Biomarkers
Cell Line
Vimentin
Therapeutics
Pentose Phosphate Pathway
Neoplasms
Survival
Cadherins
Microarray Analysis
Liver Neoplasms
Proteomics
Allografts
Blood Proteins
Staining and Labeling
Liver
Enzymes
Population

ASJC Scopus subject areas

  • General

Cite this

Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development. / Yen, Chia Hung; Lai, Chih Chung; Liao, Chen Chung; Wang, Sheng Fan; Liao, Yi Jen; Tung, Chien Yi; Hung, Jung Hsien; Huang, Shiu Feng; Chen, Yi Ming Arthur.

In: Scientific Reports, Vol. 7, No. 1, 3052, 01.12.2017.

Research output: Contribution to journalArticle

Yen, Chia Hung ; Lai, Chih Chung ; Liao, Chen Chung ; Wang, Sheng Fan ; Liao, Yi Jen ; Tung, Chien Yi ; Hung, Jung Hsien ; Huang, Shiu Feng ; Chen, Yi Ming Arthur. / Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{73818e61b34d4799b98b943734fd9953,
title = "Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development",
abstract = "Sarcomatoid hepatocellular carcinoma (SHC) is a rare type of HCC with significantly poorer survival than ordinary HCC. Little is known about the mechanism associated with SHC and its biomarkers and therapy. Here, we established a mouse liver cancer cell line and designated as Ymac-1. A sarcomatous appearance was observed in the allograft tumor arose from Ymac-1. Liver-secreted plasma proteins were found in Ymac-1 cultured supernatant by proteomics analysis. The positive staining of CK7, CK8, Vimentin and the suppressed expression of AFP indicated that Ymac-1 is a SHC cell line. Compared to its original tumor, an elevated level of EMT markers, N-cadherin and Vimentin, was found in Ymac-1. Ymac-1 displayed a higher migration rate and side population percentage than a mouse ordinary HCC cell line-Hepa1-6. Microarray analysis was performed to identify potential biomarkers/therapeutic targets for SHC. G6pd, a vital enzyme in pentose phosphate pathway, is highly expressed in Ymac-1. Depletion of G6pd in Ymac-1 reduced CD133 expression and sphere formation. Positive correlations between G6PD and CD133 were observed in human specimen. Higher expression of both G6PD and CD133 in tumor were associated with poor survival. In summary Ymac-1 can be a useful SHC cell model for novel biomarker and therapy development.",
author = "Yen, {Chia Hung} and Lai, {Chih Chung} and Liao, {Chen Chung} and Wang, {Sheng Fan} and Liao, {Yi Jen} and Tung, {Chien Yi} and Hung, {Jung Hsien} and Huang, {Shiu Feng} and Chen, {Yi Ming Arthur}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-03164-3",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development

AU - Yen, Chia Hung

AU - Lai, Chih Chung

AU - Liao, Chen Chung

AU - Wang, Sheng Fan

AU - Liao, Yi Jen

AU - Tung, Chien Yi

AU - Hung, Jung Hsien

AU - Huang, Shiu Feng

AU - Chen, Yi Ming Arthur

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Sarcomatoid hepatocellular carcinoma (SHC) is a rare type of HCC with significantly poorer survival than ordinary HCC. Little is known about the mechanism associated with SHC and its biomarkers and therapy. Here, we established a mouse liver cancer cell line and designated as Ymac-1. A sarcomatous appearance was observed in the allograft tumor arose from Ymac-1. Liver-secreted plasma proteins were found in Ymac-1 cultured supernatant by proteomics analysis. The positive staining of CK7, CK8, Vimentin and the suppressed expression of AFP indicated that Ymac-1 is a SHC cell line. Compared to its original tumor, an elevated level of EMT markers, N-cadherin and Vimentin, was found in Ymac-1. Ymac-1 displayed a higher migration rate and side population percentage than a mouse ordinary HCC cell line-Hepa1-6. Microarray analysis was performed to identify potential biomarkers/therapeutic targets for SHC. G6pd, a vital enzyme in pentose phosphate pathway, is highly expressed in Ymac-1. Depletion of G6pd in Ymac-1 reduced CD133 expression and sphere formation. Positive correlations between G6PD and CD133 were observed in human specimen. Higher expression of both G6PD and CD133 in tumor were associated with poor survival. In summary Ymac-1 can be a useful SHC cell model for novel biomarker and therapy development.

AB - Sarcomatoid hepatocellular carcinoma (SHC) is a rare type of HCC with significantly poorer survival than ordinary HCC. Little is known about the mechanism associated with SHC and its biomarkers and therapy. Here, we established a mouse liver cancer cell line and designated as Ymac-1. A sarcomatous appearance was observed in the allograft tumor arose from Ymac-1. Liver-secreted plasma proteins were found in Ymac-1 cultured supernatant by proteomics analysis. The positive staining of CK7, CK8, Vimentin and the suppressed expression of AFP indicated that Ymac-1 is a SHC cell line. Compared to its original tumor, an elevated level of EMT markers, N-cadherin and Vimentin, was found in Ymac-1. Ymac-1 displayed a higher migration rate and side population percentage than a mouse ordinary HCC cell line-Hepa1-6. Microarray analysis was performed to identify potential biomarkers/therapeutic targets for SHC. G6pd, a vital enzyme in pentose phosphate pathway, is highly expressed in Ymac-1. Depletion of G6pd in Ymac-1 reduced CD133 expression and sphere formation. Positive correlations between G6PD and CD133 were observed in human specimen. Higher expression of both G6PD and CD133 in tumor were associated with poor survival. In summary Ymac-1 can be a useful SHC cell model for novel biomarker and therapy development.

UR - http://www.scopus.com/inward/record.url?scp=85020384347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020384347&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-03164-3

DO - 10.1038/s41598-017-03164-3

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 3052

ER -